* Apixaban (Eliquis) is a newly approved anticoagulant used to prevent stroke and thrombus formation in patients with nonvalvular atrial fibrillation.
* Like all anticoagulants, apixaban may produce bleeding, including serious bleeding episodes. Sudden discontinuation of the drug increases the risk of stroke.